Press conference «Flu and Viral respiratory infection: how to cure? Start of a new clinical research».

On February 16th, 2012, the video-conference «Flu and viral respiratory infection: how to cure? Start of a new clinical research» passed in the Multimedia press center of RIA Novosti news agency.

PR-Premier Agency has organized the press conference devoted to the start of a new clinical research "Arbitr" for company "PHARMSTANDART". The main goal of the research is getting the additional information about safety and efficiency of the medicine Arbidol for preventive measures and treatment of flu or viral respiratory infection, including the information about the possibility of origin the resistant strains to Arbidol. Also there was represented the newest pharmacoepidemiology information about the practice of treatment of flu and other viral respiratory infection during 2010-2011.

The journalists were presented with reports by: O.I.Kiselyov - the director of Research Institute of Influenza of Ministry of Health and Social Development of the Russian Federation (tele-conference from St.-Petersburg); V.V.Maleev - the chief specialist on infectious diseases of Ministry of Health and Social Development of the Russian Federation, the deputy director of the Central research institute of epidemiology of the Ministry of Health and Social Development of the Russian Federation; I.A.Leneva - managing laboratory of experimental virology of The I. Mechnikov Research Institute of Vaccines and Sera, Russian Academy of Medical Sciences; A.A.Obukhov - the medical director of company "PHARMSTANDART".

The complex of works on the organization and press conference support was carried out by specialists of PR-Premier Agency.

Client: Фармстандарт